We are live on ! Find out more
SBCWW

SBC Medical Group Warrants
SBCWW

22 hedge funds and large institutions have $2.21M invested in SBC Medical Group Warrants in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% less funds holding

Funds holding: 27 → 22 (-5)

51% less capital invested

Capital invested by funds: $4.52M → $2.21M (-$2.31M)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

90% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 10

Holders
22
Holders Change
-5
Holders Change %
-18.52%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
10
Closed
7
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$79.6K
2
CS
Clear Street
New York
+$20.1K
3
UBS Group
UBS Group
Switzerland
+$97

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$67.1K
2
ASM
ATW SPAC Management
New York
-$67.1K
3
AA
AQR Arbitrage
Connecticut
-$62.3K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$60.3K
5
MC
Meteora Capital
Florida
-$57.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$1M -$67.1K -278,075 -61%
DAM
2
Decagon Asset Management
United Kingdom
$284K +$285K +1,181,391 New
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$189K -$60.3K -250,000 -24%
TCA
4
Taconic Capital Advisors
New York
$87.2K – – –
MI
5
MMCAP International
Cayman Islands
$79.2K +$79.6K +330,000 New
CCM
6
Context Capital Management
California
$76.2K -$26K -107,799 -25%
WAM
7
Weiss Asset Management
Massachusetts
$55K – – –
YCM
8
Yakira Capital Management
Connecticut
$50K -$2.41K -10,000 -5%
SCM
9
Saba Capital Management
New York
$49K – – –
CCC
10
Cable Car Capital
California
$47.1K – – –
AC
11
Aristeia Capital
Connecticut
$44.1K – – –
ASM
12
ATW SPAC Management
New York
$43.4K -$67.1K -277,890 -61%
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$41.4K – – –
CS
14
Clear Street
New York
$40K +$20.1K +83,269 +100%
SCM
15
Shaolin Capital Management
Florida
$30K -$24.2K -100,180 -45%
RL
16
RPO LLC
Connecticut
$24K – – –
MC
17
Meteora Capital
Florida
$21.4K -$57.4K -237,962 -73%
WAM
18
Wolverine Asset Management
Illinois
$16.3K -$30.7K -127,400 -65%
AA
19
AQR Arbitrage
Connecticut
$12.8K -$62.3K -258,340 -83%
WA
20
Whitebox Advisors
Minnesota
$8.4K – – –
QL
21
Quarry LP
New York
$6.43K -$12.8K -53,200 -67%
UBS Group
22
UBS Group
Switzerland
$96 +$97 +400 New
SIA
23
Schechter Investment Advisors
Michigan
– -$53.7K -358,150 Closed
Walleye Capital
24
Walleye Capital
New York
– -$23.8K -158,786 Closed
CAC
25
Cowen and Company
New York
– -$22.5K -149,910 Closed
1
2

SBCWW Hedge Fund Activity: Q4 2024 in Review

22 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group Warrants (SBCWW) for Q4 2024, worth a combined $2.21M — down 51% from $4.52M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SBCWW and 3 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 1 added.

The largest buyer was MMCAP International, opening a new position worth an estimated $79.6K. The largest seller was Boothbay Fund Management, cutting an estimated $67.1K.

  • 22 institutional investors held SBC Medical Group Warrants (SBCWW) as of Q4 2024, down from 27 in Q3 2024.
  • Funds reported $2.21M of SBC Medical Group Warrants stock for Q4 2024, down 51% quarter-over-quarter.
  • 3 funds opened new SBC Medical Group Warrants positions in Q4 2024 and 7 closed out, a net change of -4 holders.
  • The largest SBC Medical Group Warrants buyer in Q4 2024 was MMCAP International, an estimated $79.6K added.
  • The largest SBC Medical Group Warrants seller in Q4 2024 was Boothbay Fund Management, an estimated $67.1K sold.

Based on aggregated 13F filings for Q4 2024.